Herpes Zoster: impact on quality of life and burden
Part of Infections clinical trials.
This study looks at how herpes zoster (shingles) affects quality of life and the overall burden of the disease. It will include adults getting the shingles vaccine and also adults diagnosed with shingles in the past, to understand the condition better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are either about to get the shingles vaccine or have been diagnosed with shingles in the past (from 2012 to 2023 at the Jiménez Díaz Foundation hospital).
- You are able to fill out questionnaires (so you are not having trouble with memory or thinking).
- You are not pregnant.
- You are willing to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental shingles vaccine in adults aged 40 and older. It aims to see if the vaccine is safe and helps your body build immunity against shingles.
This study tests a new shingles vaccine for people 40 and older. It looks at safety, how well the body responds, and whether it can prevent shingles.
This study tests a new shingles vaccine to make sure each batch works the same way. If you are 40 or older and have never had shingles or the shingles vaccine, you may qualify.
This trial tests a new shingles vaccine to see how well it prevents shingles in adults aged 40 and older. It aims to help those who have not had shingles recently or been vaccinated against it before.
This trial tests a new mRNA vaccine (IN001) to prevent shingles. It is for healthy adults aged 50 to 79 who have never had shingles or been vaccinated against it.
This trial tests a new mRNA vaccine to prevent shingles (herpes zoster). It checks if the vaccine is safe and helps your body build immunity. It's for adults aged 40 or older (phase 1) or 50+ (phase 2).
Hear when a new Herpes Zoster trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.